Nuvation Bio

We recently had the privilege of meeting with members of The ROS1ders community to better understand their journeys with #ROS1 positive #cancers, including #NSCLC. The stories and insights had a profound impact on us, reinforcing our commitment to advancing treatment options and improving patient outcomes. Swipe through to see our key takeaways. 👇

We are thrilled to join The ROS1ders’ PRIME Summit starting tomorrow! We look forward to connecting with patients, caregivers and advocates impacted by #ROS1 positive #cancers and supporting the event as a platinum sponsor. Learn more about how this organization works to improve outcomes for all ROS1-positive cancers through community, education and research: https://lnkd.in/ee39X9Gi #oncology #NSCLC #lungcancer 

Today we reported second quarter 2024 financial results and provided a business update. See more: https://bit.ly/4dskiLK #oncology #cancer #biotech

Amy Muse, Vice President of Commercial Ops & Strategic Insights, has always held a deep-seated desire to be part of a team that brings new #cancer medicines to patients. At Nuvation Bio, she appreciates the ability to collaborate across functions to advance our common goal. Learn more about how our team works together: https://lnkd.in/geQFgga 

We are pleased to share updates on our investigational ROS1 inhibitor for #NSCLC and look forward to presenting data to the #oncology community at #WCLC24 and #ESMO24 in September. Read more: https://lnkd.in/ehg5fEtY

We are hiring! If you are passionate about developing innovative new medicines with the potential to improve the lives of people with #cancer, check out our open roles. Our team is growing, and we have positions open in #CommercialOps, #MarketAccess, #MedicalAffairs, #TechOps and #IT. https://rb.gy/vftzqb    #biotech #oncology

Qi Gong, Director, Biostatistics, enjoys working on statistics, programming and data management to further Nuvation’s mission to tackle some of the greatest unmet needs in #oncology. Exploring and resolving other functions’ needs through data science fulfils his knowledge and logical thinking strengths.

We enjoyed presenting our data, connecting with the #oncology community and celebrating exciting advances for people with #cancer at #ASCO24! Thanks to the Nuvation Bio team and our collaborators for their dedication and impact. Explore our updates: Press release: https://lnkd.in/eKaZ3dkg Oral presentation and Journal of Clinical Oncology publication: https://lnkd.in/e76cYDpG

#ASCO24 News: We are excited to announce data from the pivotal Phase 2 TRUST-I study of our investigational ROS1 inhibitor for #NSCLC are published in the American Society of Clinical Oncology (ASCO) Journal of Clinical Oncology. If you’re in Chicago, we hope to see you at the oral presentation today at 4:30 p.m. CT. Read more: https://lnkd.in/eKaZ3dkg   #oncology #cancer

Next Wednesday, management will be presenting at the Jefferies Global Healthcare Conference. Tune in to hear about our pipeline of multiple clinical #oncology programs: https://lnkd.in/e3A8Sdcu